ONALABS Healthcare was born as an ambitious, technological and emotional Project for the development of non-invasive clinical monitoring Systems by means of chemical microsensors and miniaturized biosensors. And was born from the newborn, from the beginning of life, from the situation of infants with congenital heart disease who have undergone surgery and require thorough monitoring in the Intensive Care Unit (ICU). Those children are subjected to 6-8 daily blood extractions to analyze a series of physiological parameters: lactate, pH, CO2 and glucose. Para ello se les introduce una vía -catéter- exclusiva para las extracciones. In 10 days of average stay in the ICU is extracted ¼ part of their body blood, 62.5 ml of the 250 ml of total blood, with the consequences that this implies.
Our business Project began in December 2016 as a result of the joining of a clinician, a scientist, an expert in innovation and an expert in business management, with the aim to reduce and minimize as much as possible these situations of hospitalization that chronic patients suffer from, and to provide them a greater degree of well-being and quality of life. In addition, economic benefits will be obtained in reducing expenditure of the health system by applying the non-invasive monitoring solution that we propose.